Search Results - "Ebenezer, Rajadas"
-
1
Fabrication of bioactive rifampicin loaded κ-Car-MA-INH/Nano hydroxyapatite composite for tuberculosis osteomyelitis infected tissue regeneration
Published in International journal of pharmaceutics (30-06-2019)“…[Display omitted] Biocompatible polymers and ceramic materials have been identified as vital components to fabricate drug delivery and tissue engineering…”
Get full text
Journal Article -
2
Differential Culturability of Mycobacterium tuberculosis in Culture-Negative Sputum of Patients With Pulmonary Tuberculosis and in a Simulated Model of Dormancy
Published in Frontiers in microbiology (23-10-2019)“…Tuberculosis (TB) remains a leading killer among infectious diseases of humans worldwide. Delayed diagnosis is a crucial problem in global TB control programs…”
Get full text
Journal Article -
3
In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor
Published in PloS one (03-03-2023)“…This study involves the in-vitro and in-vivo anti-TB potency and in-vivo safety of Transitmycin (TR) (PubChem CID:90659753)- identified to be a novel secondary…”
Get full text
Journal Article -
4
Protective effect of antigen excess immune complex in guinea pigs infected with Mycobacterium tuberculosis
Published in Indian journal of medical research (New Delhi, India : 1994) (01-11-2017)“…Background & objectives: Immune complexes (ICs) play a crucial role which can either be beneficial or pathological to the host. Involvement of circulating…”
Get full text
Journal Article -
5
Discovery of a highly potent novel rifampicin analog by preparing a hybrid of the precursors of the antibiotic drugs rifampicin and clofazimine
Published in Scientific reports (13-01-2021)“…Tuberculosis (TB) is an infectious disease caused by the bacillus Mycobacterium tuberculosis (Mtb). The present work reports the design and synthesis of a…”
Get full text
Journal Article -
6
Versatile pH-Responsive Chitosan-g-Polycaprolactone/Maleic Anhydride–Isoniazid Polymeric Micelle To Improve the Bioavailability of Tuberculosis Multidrugs
Published in ACS applied bio materials (20-05-2019)“…The potential of polymeric micelles constructed by coalescing natural and synthetic polymers for tuberculosis (TB) treatment was evaluated in this work. We…”
Get full text
Journal Article -
7
Functionalized chitosan-G-poly caprolactone vaccine delivery system fabricated to display antigen–antibody immune complexes of Mycobacterium tuberculosis elicits immune response in Ex-vivo model
Published in Beni-Suef University journal of basic and applied sciences (01-12-2024)“…Background Vaccine development against tuberculosis remains a global health imperative, necessitating robust immunogenicity and safety profiles…”
Get full text
Journal Article -
8
Wild-Type MIC Distribution for Re-evaluating the Critical Concentration of Anti-TB Drugs and Pharmacodynamics Among Tuberculosis Patients From South India
Published in Frontiers in microbiology (30-06-2020)“…The World Health Organization (WHO) has developed specific guidelines for critical concentrations (CCs) of antibiotics used for tuberculosis (TB) treatment,…”
Get full text
Journal Article -
9
Dodecanoic acid & palmitic acid disarms rifampicin resistance by putatively targeting mycobacterial efflux pump Rv1218c
Published in Indian journal of medical research (New Delhi, India : 1994) (01-02-2023)“…Background & objectives: Drug-resistant tuberculosis (TB) jeopardizes the treatment process with poor outcomes. Efflux pumps (EPs) belonging to the ABC…”
Get full text
Journal Article -
10
Anti-tuberculosis activity of bio-active compounds from Lantana camara L., Euphorbia hirta L., Mukia maderaspatana (L.) M. Roem, and Abutilon indicum (L.)
Published in European journal of integrative medicine (01-04-2020)“…Tuberculosis (TB) is a major cause of morbidity and mortality and deserves global attention to identify new effective drugs. The present in-vitro study is an…”
Get full text
Journal Article -
11
Myoinositol and methyl stearate increases rifampicin susceptibility among drug‐resistant Mycobacterium tuberculosis expressing Rv1819c
Published in Chemical biology & drug design (01-04-2023)“…The alarming increase in multidrug resistance, which includes Bedaquiline and Delamanid, stumbles success in Tuberculosis treatment outcome. Mycobacterium…”
Get full text
Journal Article